Andrew Kelly

Corporate Officer/Principal en The University of Newcastle .

Consumer Services

Commercial Services

Perfil

Andrew Kelly is currently working as a Principal at The University of Newcastle.
Previously, he worked as a Chief Scientific Officer at Biotecnol-Serviços e Desenvolvimento SA. He holds a doctorate degree from King's College London.

Cargos activos de Andrew Kelly

Empresas	Cargo	Inicio
The University of Newcastle	Corporate Officer/Principal	-

Todos los cargos activos de Andrew Kelly

Antiguos cargos conocidos de Andrew Kelly.

Empresas	Cargo	Fin
Biotecnol-Serviços e Desenvolvimento SA Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.	Director Técnico/Científico/I+D	-

Ver el detalle de la experiencia de Andrew Kelly.

Formación de Andrew Kelly.

King's College London

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andrew Kelly.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	1
Biotecnol-Serviços e Desenvolvimento SA Biotecnol-Serviços e Desenvolvimento SA Miscellaneous Commercial ServicesCommercial Services Biotecnol-Serviços e Desenvolvimento SA engages in the discovery, engineering, and development of multifunctional antibody molecules, directed to key therapeutic targets. The firm operates as a biopharmaceutical company working in the field of immuno-oncology. It uses Tribody technology to develop a pipeline of in-house discovered products in selected oncology indications. The company was founded in 1997 and is headquartered in Oeiras, Portugal.	Commercial Services